Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Bo Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-6595-3744; OpenAlex author ID A5104322251. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2012: 3 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers

Papers 5

  1. The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics. Last author DOI 10.1016/j.bbcan.2023.188943↗
  2. A case of pancreatic cancer treated with chemotherapy combined with immunotherapy and targeted therapy. Co-author DOI 10.3724/zdxbyxb-2023-0258↗
  3. DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer. Co-author DOI 10.1007/s00432-012-1205-3↗
  4. Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Co-author DOI 10.3892/ol.2012.783↗
  5. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Co-author DOI 10.3892/ol.2012.784↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kezhong Tang · 1 shared paper, 2023 · strength 0.31
  2. Xin Dong · 1 shared paper, 2023 · strength 0.31
  3. Xin Zhang · 1 shared paper, 2023 · strength 0.24
  4. Jiwei Qian · 1 shared paper, 2023 · strength 0.24
  5. Muxing Kang · 3 shared papers, 2012 · strength 0.11
  6. Yulian Wu · 3 shared papers, 2012 · strength 0.11
  7. Qingqu Guo · 2 shared papers, 2012 · strength 0.07
  8. Ying Chen · 2 shared papers, 2012 · strength 0.07
  9. Wenjie Lu · 1 shared paper, 2012 · strength 0.04
  10. Gang Wang · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.